Natera (NTRA) Cash from Investing Activities (2014 - 2026)
Natera's (NTRA) quarterly Cash from Investing Activities came in at -$32.1 million in Q1 2026, down 91.12% YoY from -$361.9 million in Q1 2025, and up 55.11% on a QoQ basis from -$71.6 million in Q4 2025.
Natera (NTRA) Cash from Investing Activities (2014 - 2026) Analysis & Trends
Natera (NTRA) has 13 years of Cash from Investing Activities data on file, last reported at -$32.1 million in Q1 2026.
- Quarterly Cash from Investing Activities fell 91.12% year-over-year to -$32.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$147.5 million (down 745.64% YoY) and the FY2025 annual result came in at -$132.2 million, down 196.07% from the prior year.
- Cash from Investing Activities advanced to -$32.1 million in Q1 2026, from -$71.6 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $207.0 million in Q1 2022 to a low of -$71.6 million in Q4 2025.
- A 5-year average of $27.8 million and a median of $21.9 million in 2022 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities jumped 771.17% — and 2025, when it sank 543.93%.
- Tracing NTRA's Cash from Investing Activities over 5 years: stood at $21.9 million in 2022, then gained by 10.17% to $24.1 million in 2023, then slumped by 146.05% to -$11.1 million in 2024, then slumped by 543.93% to -$71.6 million in 2025, then jumped by 55.11% to -$32.1 million in 2026.
- The last three Cash from Investing Activities figures came in at -$32.1 million (Q1 2026), -$71.6 million (Q4 2025), and -$19.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 164.00 Mn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -10.15 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -25.50 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -77.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -381.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -32.14 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -122.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -1.94 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -134.00 Mn |
| 10 | Labcorp Holdings | 25.87 Bn | 24.89 Bn | 1.01 Bn | -322.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.14 Mn |
| Mar 31, 2026 | -32.14 Mn |
| Dec 31, 2025 | -71.59 Mn |
| Dec 31, 2025 | -71.59 Mn |
| Sep 30, 2025 | -19.91 Mn |
| Sep 30, 2025 | -19.91 Mn |
| Jun 30, 2025 | -23.90 Mn |
| Jun 30, 2025 | -23.90 Mn |
| Mar 31, 2025 | -16.82 Mn |
| Mar 31, 2025 | -16.82 Mn |
| Dec 31, 2024 | -11.12 Mn |
| Dec 31, 2024 | -11.12 Mn |
| Sep 30, 2024 | 42.54 Mn |
| Sep 30, 2024 | 42.54 Mn |
| Jun 30, 2024 | -32.05 Mn |
| Jun 30, 2024 | -32.05 Mn |
| Mar 31, 2024 | 138.26 Mn |
| Mar 31, 2024 | 138.26 Mn |
| Dec 31, 2023 | 24.15 Mn |
| Dec 31, 2023 | 24.15 Mn |